Real-time enrollment status for this hormone receptor positive breast carcinoma clinical trial
Current Status
Recruiting
Checked: September 1, 2026 at 12:18 AM UTC
| NCT Number | NCT07737951 |
| Recruiting Status | Recruiting |
| Condition | Hormone Receptor Positive Breast Carcinoma |
| Phase | NA |
| Target Enrollment | 40 participants |
| Active Locations | 1 sites in the US |
| Sponsor | Thomas Jefferson University |
| Last Updated on CT.gov | August 14, 2026 (2 weeks ago) |
As of September 1, 2026: Clinical trial NCT07737951 is currently recruiting participants. This na study for hormone receptor positive breast carcinoma is actively seeking new participants at 1 location across the United States. The study is sponsored by Thomas Jefferson University. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07737951 is actively recruiting participants as of September 1, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07737951 was last updated 2 weeks ago (August 14, 2026). HelloStudys verifies this status automatically.